Voxelotor, sold under the brand name Oxbryta, was a medication used for the treatment of sickle cell disease. Voxelotor is the first hemoglobin oxygen-affinity modulator. From Wikipedia
The drug promises to significantly improve life quality and reduce hospital visits for thousands.
